24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
66.67% |
|
IL 2 RECEPTOR DYNAMICS |
18.52% |
|
UNSPECIFIED |
14.81% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
54.55% |
|
ENZYME DYNAMICS |
18.66% |
|
IL 2 RECEPTOR DYNAMICS |
14.83% |
|
ANTIBODY AFFINITY MATURATION |
5.26% |
|
ALZHEIMERS |
4.78% |
|
UNSPECIFIED |
1.91% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
32.43% |
|
ALZHEIMERS |
21.91% |
|
ANTIBODY DYNAMICS |
12.45% |
|
ENZYME DYNAMICS |
10.42% |
|
IL 2 RECEPTOR DYNAMICS |
9.94% |
|
ANTIBODY AFFINITY MATURATION |
8.49% |
|
ANTIBODY MATURATION SIMULATION |
1.93% |
|
IL 2 FORCE FIELD BENCHMARKING |
1.06% |
|
IL 2 MOLECULAR DYNAMICS |
.48% |
|
CANCER |
.48% |
|
UNSPECIFIED |
.39% |